Article information
Full text is only aviable in PDF
Bibliografía
[1.]
M. Decramer, R. Gosselink, T. Troosters, M. Verschueren, G. Evers.
Muscle weakness is related to utilization of health care resources in COPD patients.
Eur Respir J, 10 (1997), pp. 417-423
[2.]
S. Bernard, P. LeBlanc, F. Whittom, G. Carrier, J. Jobin, R. Belleau, F. Maltais.
Peripheral muscle weakness in patients with chronic obstructive pulmonary disease.
Am J Respir Crit Care Med, 158 (1998), pp. 629-634
[3.]
R. Gosselink, T. Troosters, M. Decramer.
Peripheral muscle weakness contributes to exercise limitation in COPD.
Am J Respir Crit Care Med, 153 (1996), pp. 976-980
[4.]
R. Casaburi.
Skeletal muscle function in COPD.
Chest, 117 (2000), pp. S267-S271
[5.]
Skeletal muscle dysfunction in chronic obstructive pulmonary disease: a statement of the American Thoracic Society and European Respiratory Society.
Am J Respir Crit Care Med, 159 (1999), pp. S1-S40
[6.]
E. Sala, J. Roca, R.M. Marrades, J. Alonso, J.M. González, A. Moreno, J.A. Barbera, J. Nadal, L. de Jover, R. Rodríguez-roisin, P.D. Wagner.
Effect of endurance training on skeletal muscle bioenergetic in chronic obstructive pulmonary disease.
Am J Respir Crit Care Med, 159 (1999), pp. 1726-1734
[7.]
A. Satta, G.B. Migliori, A. Spanevello, M. Neri, R. Bottinello, M. Canepari, M.A. Pellegrino, C. Reggiani.
Fiber types in skeletal muscles of chronic obstructive pulmonary disease patients related to respiratory function and exercise tolerance.
Eur Respir J, 10 (1997), pp. 2853-2860
[8.]
H. Gosker, E. Wouters, G.J. Van der Vusse, A.M. Schols.
Skeletal muscle dysfunction in chronic obstructive pulmonary disease and chronic heart failure: underlying mechanisms and therapy perspectives.
Am J Clin Nutr, 71 (2000), pp. 1033-1047
[9.]
A.L. Hamilton, K.J. Killian, E. Summers, N.L. Jones.
Muscle strength symptom intensity, and exercise capacity in patients with cardiorespiratory disorders.
Am J Respir Crit Care Med, 152 (1995), pp. 2021-2031
[10.]
M. Montes de Oca, J. Rassulo, B. Celli.
Respiratory muscle and cardiopulmonary function during exercise in very severe COPD.
Am J Respir Crit Care Med, 154 (1996), pp. 1284-1289
[11.]
M. Montes de Oca, B. Celli, J. Rassulo.
Progresión de la disfunción de los músculos respiratorios en pacientes con enfermedad obstructiva crónica severa.
Arch Bronconeumol, 33 (1997), pp. 561-565
[12.]
M. Montes de Oca, B.R. Celli.
Respiratory muscle recruitment and exercise performance in eucapnic and hypercapnic severe chronic obstructive pulmonary disease.
Am J Respir Crit Care Med, 161 (2000), pp. 880-885
[13.]
K.J. Killian, P. Leblanc, D.H. Martin, E. Summers, N.L. Jones, E.J. Campbell.
Exercise capacity and ventilatory, circulatory, and symptom limitation in patients with chronic airflow limitation.
Am Rev Respir Dis, 146 (1992), pp. 935-940
[14.]
E. Servera, M. Giménez, T. Mohan-Kumar, R. Candina, J.B. Bonassis.
Oxygen uptake at maximal exercise in chronic airflow obstruction.
Bull Europ Physiopathol Respir, 19 (1983), pp. 553-556
[15.]
D.A. Mahler, A. Harver.
Prediction of peak oxygen consumption in obstructive airway disease.
Med Sci Sports Exerc, 20 (1988), pp. 574-578
[16.]
M.J. Belman.
Exercise in patients with chronic obstructive pulmonary disease.
Thorax, 48 (1993), pp. 936-946
[17.]
M. Montes de Oca, B.R. Celli.
Prueba de esfuerzo cardiopulmonar en pacientes con enfermedad pulmonar obstructiva crónica.
Arch Bronconeumol, 33 (1997), pp. 582-587
[18.]
R. Casaburi, A. Patessio, F. Ioli, S. Zanaboni, C.F. Donner, K. Wasserman.
Reduction in exercise lactic acidosis and ventilation as a result of exercise training in patients with chronic obstructive pulmonary disease.
Am Rev Respir Dis, 143 (1991), pp. 9-18
[19.]
F. Maltais, J. Jobin, M.J. Sullivan, S. Bernard, F. Whittom, K.J. Killian, M. Desmeneules, M. Belanger, P. LeBlanc.
Lower limb metabolic and hemodynamic responses during exercise in normal subjects and in COPD.
J Appl Physiol, 84 (1998), pp. 1574-1580
[20.]
F. Maltais, A.A. Simard, C. Simard, J. Jobin, P. Desgagnes, P. Leblanc.
Oxidative capacity of the skeletal muscle and lactic acid kinetics during exercise in normal subjects and in COPD.
Am J Respir Crit Care Med, 153 (1996), pp. 288-293
[21.]
F. Maltais, P. Leblanc, C. Simard, J. Jobin, C. Berube, J. Bruneau, L. Carrier, R. Belleau.
Skeletal muscle adaptation to endurance training in patients with chronic obstructive pulmonary disease.
Am J Respir Crit Care Med, 154 (1996), pp. 442-447
[22.]
P. Jakobsson, L. Jorfeldt, A. Brundin.
Skeletal muscle metabolites and fiber types in patients with advanced chronic obstructive pulmonary disease (COPD), with and without chronic respiratory failure.
Eur Respir J, 3 (1990), pp. 192-196
[23.]
F. Whittom, J. Jobin, P.M. Simard, P. LeBlanc, P., S. Simard, R. Belleau, F. Maltais.
Histochemical and morphological characteristics of the vastus lateralis muscle in COPD patients.
Med Sci Sports Exerc, 30 (1998), pp. 1467-1474
[24.]
J. Jobin, F. Maltais, J.F. Doyon, P. LeBlanc, A.A. Simard, C. Simard.
Chronic obstructive pulmonary disease: capillarity and fiber-type characteristics of skeletal muscle.
J Cardiopulm Rehab, 18 (1998), pp. 432-437
[25.]
P. Jakobsson, L. Jorfeldt, J. Heriksson.
Metabolic enzyme activity in the quadriceps femoris muscle in patients with severe chronic obstructive pulmonary disease.
Am J Respir Crit Care Med, 151 (1995), pp. 374-377
[26.]
J.F. Payen, B. Wuyam, P. Levy, et al.
Muscular metabolism during oxygen supplementation in patients with chronic hipoxemia.
Am Rev Respir Dis, 147 (1993), pp. 592-598
[27.]
D. Arnold, P. Mathews, G. Radda.
Investigation of human mitochondrial myopathies by phosphorus magnetic resonance spectroscopy.
Ann Neurol, 18 (1995), pp. 189-196
[28.]
D. Lipkin, D. Jones, J. Round, et al.
Abnormalities of skeletal muscle in patients with chronic heart failure.
Int J Cardiol, 18 (1988), pp. 187-195
[29.]
M.J. Sullivan, H.J. Green, F.R. Cobb.
Skeletal muscle biochemistry and hystology in ambulatory patient with long-term heart failure.
Circulation, 81 (1990), pp. 518-527
[30.]
H. Drexler, U. Riede, T. Munzel, et al.
Alteration of skeletal muscle in chronic heart failure.
Circulation, 85 (1992), pp. 1571-1579
[31.]
M.J. Sullivan, H.J. Green, F.R. Cobb.
Altered skeletal muscle metabolic response to exercise in chronic heart failure: relation to skeletal muscle aerobic enzyme activity.
Circulation, 84 (1991), pp. 1597-1607
[32.]
M.A. Ralston, A.J. Merola, C.V. Leier.
Depressed aerobic enzyme activity of skeletal muscle in severe chronic heart failure.
J Lab Clin Med, 117 (1991), pp. 370-372
[33.]
R. Casaburi, T.W. Storer, K. Wasserman.
Mediation of reduced ventilatory response to exercise after endurance training.
J Appl Physiol, 63 (1987), pp. 1533-1538
[34.]
S.A. Bloomfield.
Changes in musculoskeletal structure and function with prolonged bed rest.
Med Sci Sports Exerc, 29 (1997), pp. 197-206
[35.]
H.E. Berg, P.A. Tesch.
Changes in muscle function in response to 10 days of lower limb unloading in humans.
Acta Physiol Scand, 157 (1996), pp. 63-70
[36.]
R.L. Terjung, G.A. Dudley, R.A. Meyer.
Metabolic and circulatory limitations to muscular performance at the organ level.
J Exp Biol, 115 (1985), pp. 307-318
[37.]
J. Heriksson, J.S. Reitman.
Time course of changes in human skeletal muscle succinate dehydrogenase and cytochrome oxidase activities and maximal oxygen uptake with physical activity and inactivity.
Acta Physiol Scand, 99 (1997), pp. 91-97
[38.]
J. Clapés Estapá.
Nutrición en la enfermedad respiratoria crónica.
Arch Bronconeumol, 30 (1994), pp. 70-73
[39.]
M.F. Muers, J.H. Green.
Weight loss in chronic obstructive pulmonary disease.
Eur Respir J, 6 (1993), pp. 729-734
[40.]
A.M. Schols, W.A. Buurman, Staal van den Brekel, et al.
Evidence for a relation between metabolic derangements and increased levels of inflammatory mediators in a subgroup of patients with chronic obstructive pulmonary disease.
Thorax, 51 (1996), pp. 819-824
[41.]
M.D. Francia, D. Barbier, J.L. Mege, J. Orejek.
Tumor necrosis factor- alpha levels and weight loss in chronic obstructive pulmonary disease.
Am J Respir Crit Care Med, 150 (1994), pp. 1453-1455
[42.]
A.M. Schols, E.C. Creutzberg, W.A. Buurman, L.A. Campfield, W.H. Saris, E.F. Wouters.
Plasma leptin is related to proinflammatory status and dietary intake in patients with chronic obstructive pulmonary disease.
Am J Respir Crit Care Med, 160 (1999), pp. 1220-1226
[43.]
A.M. Hunter, M.A. Carey, H.W. Larsh.
The nutritional status of patients with chronic obstructive pulmonary disease.
Am Rev Respir Dis, 124 (1981), pp. 376-381
[44.]
E. Vanderbergh, J.P. Van de Woestijne, A. Gyselen.
Weight changes in the terminal stages of COPD.
Am Rev Respir Dis, 95 (1967), pp. 556-565
[45.]
A.M. Schols, E.W. Fredix, P.B. Soeters, K.P. Westerterp, E.F. Wouters.
Resting energy expenditure in patients with chronic obstructive pulmonary disease.
Am J Clin Nutr, 54 (1991), pp. 983-987
[46.]
H. Hopperler, E. Kleinert, C. Schlegel, et al.
Morphological adaptations of human skeletal muscle to chronic hypoxia.
Int J Sports Med, 11 (1990), pp. S3-S9
[47.]
H. Howald, D. Pette, J.A. Simoneau, A. Uber, H. Hoppeler, P. Cerreteli.
Effect of chronic hypoxia on muscle enzyme activities.
Int J Sports Med, 11 (1990), pp. S10-S14
[48.]
J.R. Milley.
Protein synthesis during hypoxia in fetal lambs.
Am J Physiol, 252 (1987), pp. E519-E524
[49.]
A. Ishihara, K. Itoh, Y. Oishi, M. Itoh, C. Hirofuji, H. Hayashi.
Effects of hypobaric hypoxia on histochemical fibre type composition and myosin heavy chain isoform component in the rat soleus muscle.
Pfluger Arch, 429 (1995), pp. 601-606
[50.]
J. Sauleda, F. Garcia-palmer, R.J. Wiesner, et al.
Cytochrome oxidase activity and mitochondrial gene expression in skeletal muscle of patients with chronic obstructive pulmonary disease.
Am J Respir Crit Care Med, 157 (1998), pp. 1413-1417
[51.]
E. Jansson, J. Johansson, C. Sylven, L. Kaijser.
Calf muscle adaptation in intermittent claudication. Side-differences in muscle metabolic characteristics in patients with unilateral arterial disease.
Clin Physiol, 8 (1998), pp. 17-29
[52.]
F. Lundgren, A.-.G. Dahllof, T. Schersten, A.C. Bylund-Fellenius.
Muscle enzyme adaptation in patients with peripheral insufficiency: spontaneous adaptation, effect of different treatment and consequences on walking performance.
Clin Sci, 77 (1989), pp. 485-493
[53.]
M. DeCramer, V. DeBock, R. Dom.
Functional and histologic picture of steroid-induced myopathy in chronic obstructive pulmonary disease.
Am J Respir Crit Care Med, 153 (1996), pp. 1958-1964
Copyright © 2001. Sociedad Española de Neumología y Cirugía Torácica
